skip to content

Investors

Roche has hosted a virtual event on Monday, 23 June 2025


A gloved hand in a lab coat holds a small, clear vial against a blurred background of lab equipment, conveying a scientific and clinical setting.

Roche has hosted a Diagnostics Day on Tuesday, 27th May 2025.



Illustration of Roche equipment

patients were treated with Roche medicines in 2024

Roche Diagnostics test were delivered to customers worldwide in 2024

Core investments in research and development in 2024: CHF 13.2 billion

Product PipelineWhy Invest

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.

Portrait of Thomas Schinecker

Dr Thomas Schinecker

CEO Roche Group

Upcoming Investor events

View all events

Roche Half Year Results 2025 (virtual event)Investors

July 24, 2025 at 14:00 CEST | Basel, Switzerland

UBS Precision Medicine Frontiers SummitInvestors

August 14, 2025 at 10:00 PDT | Dana Point, US

22nd Annual Goldman Sachs European Medtech and Healthcare Services ConferenceInvestors

September 04, 2025 at 08:00 BST | London, UK

Morgan Stanley 23rd Annual Global Healthcare ConferenceInvestors

September 09, 2025 at 08:30 EST | New York, US

Nephron Napa Summit 2025Investors

September 17, 2025 at 10:00 PDT | Yountville, US

Roche's Pharma Day 2025Investors

September 22, 2025 at 09:00 BST | London, UK

Investor relations team contacts

Do you need to get in touch with us? Reach out to our investor relations team with your enquiries.

View investor contact detail